Drug Type Small molecule drug |
Synonyms H-1129, WP 1303 |
Target |
Mechanism HSP90 inhibitors(Heat shock 90kDa proteins inhibitors), ROCK2 inhibitors(Rho-associated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 3 | JP | 06 Sep 2019 | |
Glaucoma | Phase 2 | JP | 01 Jul 2018 | |
Glaucoma | Phase 2 | - | - | 01 Jul 2018 |
Choroidal Neovascularization | Preclinical | JP | 07 May 2017 | |
Choroidal Neovascularization | Preclinical | - | 07 May 2017 |
Phase 2 | - | fgaddwctyt(xrzplwccnx) = koqxjcuvyb qwcgfgiltd (soguwktfoi ) View more | Positive | 07 May 2017 | |||
lqwdsldewm(mdfpkywawt) = hulckhcynz cmgomiotbj (zgeaejlvji ) |